Oral Wegovy (Semaglutide Pill) Patients now have an alternative to injectable treatments with the FDA-approved Wegovy pill which uses the same proven GLP-1 mechanism
doi:10.1146/annurev-nutr-071816-064634
Considering the body weight reduction of more than 10% and the significant improvement in glycemic parameters without an increased risk of hypoglycemia, this trial establishes the efficacy and safety of the 7.2 mg dose of semaglutide compared with placebo in adults with obesity and type 2 diabetes, Lingvay and colleagues wrote.
Through their podcasts and public discussions, they shed light on scientifically backed methods for living healthier and longer
Select an appropriate injection siteabdomen, thigh, or upper arm as directedand rotate sites to prevent lipohypertrophy (tissue thickening) that can affect absorption
doi:10.2337/dc17-1200 Holst JJ, Vilsbll T, Deacon CF